In recent years, the combination regimen of gemcitabine and cisplatin (GC) has demonstrated equivalent efficacy as well as lower toxicity, and has become largely the regimen of choice, despite a slight trend toward greater efficacy with MVAC therapy [ 4 ].
← all excerpts
Role of consolidative surgical therapy in patients with locally advanced or regionally metastatic bladder cancer.
1
—
—